secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0000950170-24-092728
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical Q2 net sales $99.0M (record), EPS $0.15, raises FY2024 guidance
------------------------------------------------------------------------------

- Record Q2 net sales of $99.0M (up 7% YoY); constant currency $100.4M (+9%).
- Net income $7.4M ($0.15 diluted EPS) vs $6.1M ($0.12) YoY; Adjusted EBITDA $22.5M ($0.45).
- Gross margin improved to 79.2% from 76.6% YoY, helped by cataract IOL reserve changes.
- U.S. ICL sales $5.5M (+25% YoY, +10% sequentially); China ICL sales +3% YoY.
- FY2024 net sales guidance raised to $340M-$345M (from $335M-$340M); Adjusted EBITDA ~$42M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017024092728/0000950170-24-092728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017024092728/staa-20240807.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-092728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer